Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-26-052922
Filing Date
2026-05-06
Accepted
2026-05-06 17:25:32
Documents
14
Period of Report
2026-04-29
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 8-K ea0289503-8ka1_osr.htm   iXBRL 8-K/A 35976
2 FAIRNESS OPINION OF AVANCE LIFE SCIENCES AG, DATED APRIL 21, 2026 ea028950301ex99-2.htm EX-99.2 196681
3 GRAPHIC ea028950301_ex99-2img1.jpg GRAPHIC 3628
  Complete submission text file 0001213900-26-052922.txt   484750

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE osrh-20260429.xsd EX-101.SCH 3865
5 XBRL DEFINITION FILE osrh-20260429_def.xml EX-101.DEF 26754
6 XBRL LABEL FILE osrh-20260429_lab.xml EX-101.LAB 36956
7 XBRL PRESENTATION FILE osrh-20260429_pre.xml EX-101.PRE 25378
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0289503-8ka1_osr_htm.xml XML 6083
Mailing Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004
Business Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004 425-635-7700
OSR Holdings, Inc. (Filer) CIK: 0001840425 (see all company filings)

EIN.: 845052822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-41390 | Film No.: 26949839
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)